HomeMarket News Aadi Bioscience Faces Stock Plunge After...

Aadi Bioscience Faces Stock Plunge After Study Data for Anti-Tumor Drug Aadi Bioscience Faces Stock Plunge After Study Data for Anti-Tumor Drug

Actionable Trade Ideas

always free

Close-Up Of Pipette Dripping Chemical In Test Tube At Laboratory

Kwanchai Lerttanapunyaporn / EyeEm

Shares of Aadi Bioscience (NASDAQ:AADI) took a nosedive by 57% in after-hours trading Thursday on the heels of disappointing data from a registrational study for its drug candidate nab-sirolimus in treating patients with solid tumors housing pathogenic inactivating alterations of the

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.